日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Drugmakers step up efforts for innovative product R&D

By ZHENG YIRAN | China Daily | Updated: 2020-06-30 09:29
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo/LYU LIANG FOR CHINA DAILY]

Favorable policies spur transformation as profit margins for generic drugs shrink

Pharmaceutical enterprises from home and abroad are stepping up efforts in innovative drug research and development as the domestic innovation environment constantly improves and profit margins for generic drugs gradually shrink, said industry experts.

Zhang Lichao, a senior researcher at Guosen Securities, said both domestic and international pharmaceutical firms in China are undergoing innovative transformation. They have stronger innovation momentum, and have been constantly expanding investment in R&D.

"With favorable policies for innovative drugs and reducing profits for generic drugs, innovation has become the only way for the development of high-quality pharmaceutical enterprises," Zhang said.

On June 11, United States-based biopharmaceutical giant Bristol-Myers Squibb unveiled a new corporate brand in China after its integration with US-based biotech company Celgene in November. BMS also announced its new strategy on the Chinese mainland, in which it plans to introduce up to 30 innovative products or indications to the market in the coming five years, many of which have potential to become first-in-class or best-in-class.

Chen Siyuan, president of BMS Chinese mainland and Hong Kong, said: "BMS has the world's most cutting-edge technology and R&D platform, with leading drug R&D capabilities in three major areas: chemistry, biologics and cell therapy. China is one of BMS' most important R&D, manufacturing, commercial and innovation centers. In the future, we will continue to focus on bringing innovative medicines to patients with cancer and other serious diseases."

In addition, the company is focused on cultivating a culture that encourages and recognizes innovation, and nurturing Chinese executives who have a deep understanding of the market with clear vision and global perspectives.

Domestic pharmaceutical firms are also taking action. Chongqing Pharscin Pharmaceutical Co Ltd announced that it would boost drug innovation, and has introduced a chief science officer, an innovative drug business unit, innovative drug labs and an innovative drug team.

Hangzhou, Zhejiang-province-based Yifan Pharmaceutical Co Ltd also launched a small module chemicals business unit to bring about small module innovative drugs.

A China Securities report showed that in the past five years, among the top-10 frequently used drug categories in Chinese hospitals, innovative drugs are taking an increasing percentage. One supportive policy behind this is the centralized generic drug procurement policy, which effectively lowered generic drug prices and decreased their profit margins. The medical insurance negotiation also sped up the inclusion of innovative drugs into medical insurance reimbursement, promoting the rapid increase of innovative drug penetration.

"These policies made pharmaceutical enterprises' pursuit of an innovation development path an inevitable trend. In the past two years, there was an obvious growth in R&D expenditure in the chemical and pharmaceutical sector," said the report.

In 2019, most of the leading chemical and pharmaceutical enterprises in China increased their R&D investment. The growth rate of R&D spending was higher than that of the sector's overall income, the China Securities report added.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 视频一区在线 | 天天色天天色 | 日本一区免费 | 国产福利高清在线视频 | 中文字幕视频在线 | 精品国产一区二区三区久久影院 | 小明免费视频一区二区 | 亚洲福利视频一区二区 | 天天拍夜夜添久久精品中文 | 久久久久久九 | 狠狠躁日日躁夜夜躁A片小说按摩 | 欧美成人区 | 日本高清一级片 | 欧美日韩国产综合一区二区三区 | 久草视频在线资源 | 国产精品va一区二区三区 | 国产精品1区2区3区 亚洲国产aⅴ成人精品无吗 | 美腿丝袜中文字幕 | 欧美日韩中文字幕在线视频 | 99久热 | 黑色丝袜美女被狂躁 | 挑战者联盟第一季免费观看完整版 | 成人不卡| 欧美一级特黄aaaaaa在线看首页 | 一级毛片看真人在线视频 | 国产精品91久久久久久 | 欧美在线一区二区三区 | 亚洲欧美精品中字久久99 | 日本一区二区三区四区在线观看 | 亚洲精品小视频 | 日产乱码卡一卡2卡三卡四麻豆 | 小泽玛利亚一区二区 | 国产乱码一区二区三区 | 激情av免费看 | 免费看的久久久久 | 国内精品伊人久久久影视 | 激情婷婷成人亚洲综合 | 9久9久女女热精品视频免费观看 | 亚洲成人免费视频在线观看 | 国产美女亚洲精品久久久综合 | 免费又粗又硬进去好爽A片视频 |